Quantcast
logo

Liberia's Ebola drug trial starts

  • The trial of a drug that may treat Ebola has begun in Liberia, one of the west African countries hit hardest by the deadly virus.

    Ebola patients are taking the antiviral drug, brincidofovir, on a voluntary basis at the Medecins Sans Frontieres center.

    Researchers from the Oxford University, who are carrying out the study said initial results could take a few months. 

    Another study using a similar drug had started in Guinea last month.

    Tagged as: trial, drug, Ebola, Liberia, west Africa, virus, Ebola patients, brincidofovir, Guinea, technology news